Vavilov Institute of General Genetics, Russian Academy of Sciences, Gubkina str. 3, 119333 Moscow, Russia.
Vavilov Institute of General Genetics, Russian Academy of Sciences, Gubkina str. 3, 119333 Moscow, Russia.
J Glob Antimicrob Resist. 2020 Sep;22:47-53. doi: 10.1016/j.jgar.2020.01.026. Epub 2020 Feb 12.
The aim of this study was to obtain Streptomyces xinghaiensis (fradiae) ATCC 19609 mutants resistant to oligomycin A and its derivatives and to identify the underlying mechanism of resistance. This study was based on the premise that S. xinghaiensis ATCC 19609 contains several oligomycin A biological targets, explaining why the strain remains supersensitive to oligomycin A despite all efforts to obtain resistant mutants using standard genetic methods.
The method to obtain oligomycin A-resistant mutants was performed in two steps: first, mutants slightly resistant to an oligomycin A derivative with an attenuated effect were obtained; and second, oligomycin A-resistant mutants were obtained from those mutants obtained earlier. The genomes of the mutants were then sequenced and a bioinformatics analysis of the detected mutations was conducted.
Mutants with seven mutations were required to obtain oligomycin A-resistant mutant strains of S. xinghaiensis characterised by a level of resistance comparable with that of the model organism Streptomyces lividans. Five of these mutations caused amino acid substitutions in the well-known oligomycin A biological target, namely the F0F1-ATP synthase A subunit, and the others caused amino acid substitutions in unexplored biological targets, including RecB-like recombinase, type IV helicase, DNA ligase and single-domain response regulator.
A new oligomycin resistance mechanism involving a pathway that repairs double-strand breaks in DNA known as non-homologous end joining (NHEJ) was discovered.
本研究旨在获得对寡霉素 A 及其衍生物具有抗性的海洋链霉菌(弗氏链霉菌)ATCC 19609 突变株,并鉴定其抗性的潜在机制。本研究基于以下前提:海洋链霉菌 ATCC 19609 含有几个寡霉素 A 生物靶标,这解释了为什么尽管使用标准遗传方法尽一切努力获得抗性突变体,该菌株仍对寡霉素 A 保持超敏。
获得寡霉素 A 抗性突变体的方法分两步进行:首先,获得对作用减弱的寡霉素 A 衍生物略有抗性的突变体;其次,从先前获得的突变体中获得寡霉素 A 抗性突变体。然后对突变体的基因组进行测序,并对检测到的突变进行生物信息学分析。
需要七个突变才能获得海洋链霉菌的寡霉素 A 抗性突变株,其抗性水平与模型生物链霉菌 lividans 相当。其中五个突变导致了众所周知的寡霉素 A 生物靶标 F0F1-ATP 合酶 A 亚基中的氨基酸取代,而其他突变导致了未探索的生物靶标中的氨基酸取代,包括 RecB 样重组酶、IV 型螺旋酶、DNA 连接酶和单结构域反应调节剂。
发现了一种新的寡霉素抗性机制,涉及一种称为非同源末端连接(NHEJ)的修复 DNA 双链断裂的途径。